| 000 | 01522 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513070500.0 | ||
| 264 | 0 | _c19940125 | |
| 008 | 199401s 0 0 eng d | ||
| 022 | _a0959-8049 | ||
| 024 | 7 |
_a10.1016/0959-8049(93)90547-s _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGjedde, S B | |
| 245 | 0 | 0 |
_aPhase I study of tauromustine administered in a weekly schedule. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _c1993 |
||
| 300 |
_a1901-2 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukopenia _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNitrosourea Compounds _xadministration & dosage |
| 650 | 0 | 4 |
_aTaurine _xadministration & dosage |
| 650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
| 700 | 1 | _aMouridsen, H T | |
| 700 | 1 | _aL-Madsen, E | |
| 700 | 1 | _aJensen, N V | |
| 700 | 1 | _aBlomquist, E | |
| 700 | 1 | _aBergh, J | |
| 700 | 1 | _aSöderberg, M | |
| 700 | 1 | _aWählby, S | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 29A _gno. 13 _gp. 1901-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0959-8049(93)90547-s _zAvailable from publisher's website |
| 999 |
_c8259534 _d8259534 |
||